Immunotherapy With CD19 CAR T-cells for B-Cell Leukemia

NCT04100187 · clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
100
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Kecellitics Biotech Company Ltd

Collaborators